Standout Papers

MiR423-5p As a Circulating Biomarker for Heart Failure 2010 2026 2015 2020 516
  1. MiR423-5p As a Circulating Biomarker for Heart Failure (2010)
    Anke J. Tijsen, Esther E. Creemers et al. Circulation Research
  2. Cardiovascular Disease After Hodgkin Lymphoma Treatment (2015)
    Frederika A. van Nimwegen, Michael Schaapveld et al. JAMA Internal Medicine

Immediate Impact

3 from Science/Nature 65 standout
Sub-graph 1 of 18

Citing Papers

Cardiovascular Disease Risk Among Cancer Survivors
2022 Standout
Valvular Heart Disease Epidemiology
2022 Standout

Works of Wouter E.M. Kok being referenced

Cardiovascular Disease After Hodgkin Lymphoma Treatment
2015 Standout

Author Peers

Author Last Decade Papers Cites
Wouter E.M. Kok 1749 410 498 556 68 2.8k
Nadia Haddy 381 481 469 371 68 2.9k
Anders Mattsson 308 296 382 412 44 3.4k
Jonathan F. Plehn 2334 744 118 612 61 4.2k
Janine Nuver 496 773 297 383 70 1.7k
Doojduen Villaluna 554 232 337 347 42 1.9k
Ute Seeland 1153 468 100 480 55 2.0k
Patrick Collier 1991 442 103 976 101 3.1k
W. Evans 612 398 329 986 59 3.6k
Teresa López‐Fernández 2778 243 114 277 135 3.4k
Håkan Wallén 1011 385 109 919 129 3.6k

All Works

Loading papers...

Rankless by CCL
2026